A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19.
Sci Rep
; 13(1): 13809, 2023 08 23.
Article
in En
| MEDLINE
| ID: mdl-37612352
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Sci Rep
Year:
2023
Document type:
Article
Affiliation country:
Japan
Country of publication:
United kingdom